These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. NF1 Dodd RD; Lee CL; Overton T; Huang W; Eward WC; Luo L; Ma Y; Ingram DR; Torres KE; Cardona DM; Lazar AJ; Kirsch DG Cancer Res; 2017 Aug; 77(16):4486-4497. PubMed ID: 28646022 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients. Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379 [TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165 [TBL] [Abstract][Full Text] [Related]
12. Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil. Loss JF; Santos PP; Leone LD; Brunetto AL Pediatr Blood Cancer; 2004 Feb; 42(2):139-44. PubMed ID: 14752877 [TBL] [Abstract][Full Text] [Related]
13. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO). Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706 [TBL] [Abstract][Full Text] [Related]